TAKEDA PHARMACEUTICAL COMPANY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,069 JPY | -0.49% |
|
-1.86% | +0.37% |
| 10:21am | Takeda Pharmaceutical Receives FDA Approval for Single-Dose Injection Crohn's Disease Treatment | MT |
| Apr. 18 | Takeda Says FDA Has Approved Subcutaneous Entyvio for Crohn's Disease | DJ |
ETFs positioned on Takeda Pharmaceutical Company Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 24.44% | 15 M€ | +4.29% | ||
| 5.00% | 284 M€ | +19.99% | ||
| 3.80% | 1,552 M€ | +15.46% | ||
| 3.43% | 251 M€ | +13.08% | ||
| 3.26% | 57 M€ | +15.75% | ||
| 1.68% | 14 M€ | +14.35% | ||
| 1.65% | 10,207 M€ | +10.93% | ||
| 1.65% | 5,115 M€ | +11.36% | ||
| 1.50% | 73 M€ | +11.61% | ||
| 1.38% | 18 M€ | +16.15% | - | |
| 1.38% | 66,066 M€ | +12.28% | - | |
| 1.38% | 20,721 M€ | +11.13% | - | |
| 1.38% | 144,586 M€ | +12.12% | ||
| 1.34% | 26 M€ | +19.05% | ||
| 0.79% | 5 M€ | -.--% | - | |
| 0.54% | 16,729 M€ | +10.93% | - | |
| 0.53% | 31,732 M€ | +11.76% | - | |
| 0.53% | 1,198 M€ | +11.02% | - | |
| 0.50% | 26 M€ | +0.77% | - | |
| 0.46% | 717 M€ | +4.18% | ||
| 0.44% | 4 M€ | +12.04% | ||
| 0.43% | 67,864 M€ | +11.66% | ||
| 0.35% | 36 M€ | +0.21% | - | |
| 0.27% | 10 M€ | -3.35% | - |
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized around 2 areas:
- sale of drugs and consumer care products;
- services.
Net sales are distributed geographically as follows: Japan (17.5%), Asia (5%), the United States (49%), Europe and Canada (20.8%), Latin America (3.8%), Russia and CIS (1.8%) and other (2.1%).
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
4,089
JPY
Average target price
4,790
JPY
Spread / Average Target
+17.14%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.37% | 41.5B | |
| +27.97% | 672B | |
| +23.61% | 550B | |
| -7.02% | 351B | |
| +14.85% | 317B | |
| +6.25% | 292B | |
| +2.28% | 211B | |
| -0.38% | 203B | |
| -9.98% | 194B | |
| -11.81% | 144B |
- Stock Market
- Equities
- 4502 Stock
- Funds and ETFs Takeda Pharmaceutical Company Limited
